Medications FDA Approves Libtayo (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-Small Cell Lung Cancer with PD-L1 Expression of ≥50%
Health News Researchers identify specific genes and cell pathways as key players in rare female lung disease
Health News Remote, real-time monitoring of post-operative lung transplant patients significantly decreases hospital stays
